Related Experiment Video
Updated: Jun 1, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis
J Napoli1, G A Bishop, G W McCaughan
1A. W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, New South Wales, Australia.
Background/Aims:
The role of cytokines in the pathogenesis of chronic liver disease is unclear. The aim of this study was to identify intrahepatic cytokines at the messenger RNA (mRNA) level in end-stage human cirrhosis.
Methods:
Cytokine mRNA expression for interleukin (IL) 1 beta, IL-2, IL-6, IL-8, transforming growth factor beta, interferon gamma, and tumor necrosis factor alpha was examined by semiquantitative polymerase chain reaction in 25 human cirrhotic livers and 13 controls. Cellular localization of IL-8 was performed by immunohistochemistry.
Results:
The results show that IL-2 (P < 0.0001), IL-6 (P < 0.0001), IL-8 (P < 0.0001), transforming growth factor beta (P < 0.001), and interferon gamma (P < 0.04) were upregulated in human cirrhosis compared with controls. IL-1 beta and interferon gamma mRNA showed increased expression in cirrhotics with autoimmune chronic active hepatitis compared with those with primary biliary cirrhosis. Immunohistochemistry showed that IL-8 protein was expressed by infiltrating cells in portal tracts and fibrotic septae and within hepatic lobules.
Conclusions:
It is concluded that there is significant activation of cytokines at the mRNA level in end-stage cirrhosis. This suggests continued immune activation even at the late stages of cirrhosis and may indicate the importance of cytokines in the pathogenesis and progression of chronic liver disease.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology

